// App-Quantinova.ai

1541 : Evaluation of breast cancer incidence in Lynch syndrome patients by MMR gene.

Researchers

Presenter

  • Jamie Willmott

Principal Investigators

  • Adam Johnson

  • Michelle Landon

  • Kelsey Moyes

  • Brent Evans

  • Christopher Arnell

Medical Centers

  • Myriad Genetics, Inc., Salt Lake City, UT

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lynch syndrome

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Mismatch repair endonuclease PMS2

  • MutL Homolog 1

  • MutS Homolog 6

  • MutS protein homolog 2

  • Breast cancer type 1 susceptibility protein

  • Breast cancer type 2 susceptibility protein

  • Cluster of Differentiation 206

Drug/Treatment

  • N/A

Outcome

  • Positive

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved